novo
-
Health & Medicine
France Fines Novo Nordisk and Eli Lilly for Misleading Weight Loss Drug Advertisements
France’s medicine regulator has levied substantial fines against pharmaceutical giants Novo Nordisk and Eli Lilly for engaging in misleading advertising…
Read More » -
Health & Medicine
FDA Demands Transparency in Clinical Trial Reporting, While Novo Nordisk and OpenAI Forge AI-Driven Drug Discovery Partnership
The U.S. Food and Drug Administration (FDA) has initiated a significant push for greater transparency in clinical research, dispatching reminder…
Read More »
